• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Another good rep lost

































































.
Reps all over are looking. I know of several in the east who have offers and are waiting until next week to give notice. It's all over the country. It will be interesting to see who's left by the time we get to Atlanta.

I would really like a tally of how many reps have left in the past six months
1. Renee
2. Markus
3. 2 in Paul hills district/Boston
4. Second one
5. Houston
6. Dallas
7. 3 in Michiana
8. 2nd
9. 3rd
10. Florida
11. Texas
12. Texas
13. LA
14. LA
15.
 












Why are reps leaving? Outide of the shitty base salary and awful travel requirements?
The lack of a strong oncology direction is one. The whole bizarre Bill McLean experiment where we went with a bad primary care guy who was sexist and drove away key talent. And, excuse me, who the fuck is Gary Hendler? He's some hack who fooled the Japanese because he watched that five minute Alex Baldwin segment in Glengarry/Glen Ross and thought he was some hot shot sales guru....more people left after October's shit-shows.